five specialized inter and intrarun replicates ended up assessed for concordance according to methylation variant pathogenicity (MVP) score (inside 0.05) and clustering analysis. The clinical testing cohort (Table S2) includes peripheral blood DNA samples from 207 subjects, referred by physicians based upon unique scientific discretion, who defini